The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
All content for Transforming Biopharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler
Transforming Biopharma
43 minutes
7 months ago
‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler
How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice president and head of digital technology and innovation at Amgen, believes it’s time to be bold and move faster to capitalize on this opportunity. In this episode they discuss: How Amgen is using its Amgen India Center as an innovation hub to tackle key challengesHow AI and d...
Transforming Biopharma
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
